The research team engineered the fatty acid metabolism to provide the fatty acid derivatives that are shorter than normal intracellular fatty acid metabolites and introduced a novel synthetic pathway for the biosynthesis of short-chain alkanes This allowed the development of platform E.coli strain capable of producing gasoline for the first time. Furthermore this platform strain if desired can be modified to produce other products such as short-chain fatty esters and short-chain fatty alcohols.